迷幻药的多样性、公平性和可及性

IF 2.2 Q3 PHARMACOLOGY & PHARMACY
Monnica T. Williams, B. Labate
{"title":"迷幻药的多样性、公平性和可及性","authors":"Monnica T. Williams, B. Labate","doi":"10.1556/2054.2019.032","DOIUrl":null,"url":null,"abstract":"Although it is exciting to witness the culmination of decades of drug policy advocacy and clinical research, the psychedelic science movement struggles with many of the same social issues that plague healthcare in general. The healing properties of plant medicines and their derivatives were originally brought to Western consciousness by indigenous cultures from all over the world. These practices are now being adapted to Western models of healthcare, in part, to achieve governmental approval as medical treatments. The current models of psychedelic psychotherapy being utilized in clinical trials are resource-intensive and therefore likely to remain out of reach for the socioeconomically disadvantaged if approved as medical treatments. Moreover, people of color and women are uncommon in leadership positions in the psychedelic research community, and few people of color are included as research participants in psychedelic studies. This piece introduces a special issue with a focus on issues of diversity, equity, and accessibility in psychedelic medicine.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2019-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1556/2054.2019.032","citationCount":"37","resultStr":"{\"title\":\"Diversity, equity, and access in psychedelic medicine\",\"authors\":\"Monnica T. Williams, B. Labate\",\"doi\":\"10.1556/2054.2019.032\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although it is exciting to witness the culmination of decades of drug policy advocacy and clinical research, the psychedelic science movement struggles with many of the same social issues that plague healthcare in general. The healing properties of plant medicines and their derivatives were originally brought to Western consciousness by indigenous cultures from all over the world. These practices are now being adapted to Western models of healthcare, in part, to achieve governmental approval as medical treatments. The current models of psychedelic psychotherapy being utilized in clinical trials are resource-intensive and therefore likely to remain out of reach for the socioeconomically disadvantaged if approved as medical treatments. Moreover, people of color and women are uncommon in leadership positions in the psychedelic research community, and few people of color are included as research participants in psychedelic studies. This piece introduces a special issue with a focus on issues of diversity, equity, and accessibility in psychedelic medicine.\",\"PeriodicalId\":34732,\"journal\":{\"name\":\"Journal of Psychedelic Studies\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2019-12-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1556/2054.2019.032\",\"citationCount\":\"37\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Psychedelic Studies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1556/2054.2019.032\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychedelic Studies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1556/2054.2019.032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 37

摘要

虽然见证几十年来药物政策倡导和临床研究的高潮是令人兴奋的,但迷幻科学运动与困扰医疗保健的许多相同的社会问题作斗争。植物药物及其衍生物的治疗特性最初是由来自世界各地的土著文化带给西方意识的。这些做法现在正在适应西方的医疗模式,部分原因是为了获得政府的医疗批准。目前在临床试验中使用的迷幻心理治疗模式是资源密集型的,因此,如果批准作为医学治疗,社会经济上处于不利地位的人可能仍然无法获得。此外,有色人种和女性在致幻剂研究界的领导职位上并不常见,很少有有色人种被纳入致幻剂研究的研究参与者。这篇文章介绍了一个特别的问题,关注迷幻药的多样性、公平性和可及性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Diversity, equity, and access in psychedelic medicine
Although it is exciting to witness the culmination of decades of drug policy advocacy and clinical research, the psychedelic science movement struggles with many of the same social issues that plague healthcare in general. The healing properties of plant medicines and their derivatives were originally brought to Western consciousness by indigenous cultures from all over the world. These practices are now being adapted to Western models of healthcare, in part, to achieve governmental approval as medical treatments. The current models of psychedelic psychotherapy being utilized in clinical trials are resource-intensive and therefore likely to remain out of reach for the socioeconomically disadvantaged if approved as medical treatments. Moreover, people of color and women are uncommon in leadership positions in the psychedelic research community, and few people of color are included as research participants in psychedelic studies. This piece introduces a special issue with a focus on issues of diversity, equity, and accessibility in psychedelic medicine.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Psychedelic Studies
Journal of Psychedelic Studies Social Sciences-Anthropology
CiteScore
2.50
自引率
8.90%
发文量
20
审稿时长
26 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信